1. Home
  2. EFOI vs BCDA Comparison

EFOI vs BCDA Comparison

Compare EFOI & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFOI

Energy Focus Inc.

N/A

Current Price

$3.02

Market Cap

21.0M

ML Signal

N/A

BCDA

BioCardia Inc.

HOLD

Current Price

$0.89

Market Cap

17.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
BCDA
Founded
1985
N/A
Country
United States
United States
Employees
N/A
21
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
17.9M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
EFOI
BCDA
Price
$3.02
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
22.2K
796.3K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
N/A
EPS
N/A
N/A
Revenue
$3,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.78
52 Week High
$9.84
$2.42

Technical Indicators

Market Signals
Indicator
EFOI
BCDA
Relative Strength Index (RSI) 45.23 39.43
Support Level $2.75 $0.81
Resistance Level $3.10 $1.32
Average True Range (ATR) 0.18 0.11
MACD 0.02 -0.01
Stochastic Oscillator 35.71 5.38

Price Performance

Historical Comparison
EFOI
BCDA

About EFOI Energy Focus Inc.

Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: